Basics Invivyd, Inc. IPO Date: August 6, 2022 Sector: Healthcare Industry: Biotech Market Cap: $81.87M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 5.11% Avg Daily Range (30 D): $0.02 | 3.17% Avg Daily Range (90 D): $0.03 | 4.77% Institutional Daily Volume Avg Daily Volume: 1.55M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): 1.32M Trade Size Avg Trade Size (Sh.): 281 Avg Trade Size (Sh.) (30 D): 270 Avg Trade Size (Sh.) (90 D): 310 Institutional Trades Total Inst.Trades: 38 Avg Inst. Trade: $2.65M Avg Inst. Trade (30 D): $1.86M Avg Inst. Trade (90 D): $1.86M Avg Inst. Trade Volume: 1.18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.28M Avg Closing Trade (30 D): $4.4M Avg Closing Trade (90 D): $4.4M Avg Closing Volume: 2.64M     News Mar 20, 2025 @ 12:01 PM Invivyd Reports Fourth Quarter and Full-Year 2024 ... Source: N/A Nov 6, 2024 @ 1:01 PM Invivyd to Participate in the Guggenheim Securitie... Source: N/A Nov 6, 2024 @ 12:01 PM Invivyd to Host Third Quarter 2024 Financial Resul... Source: N/A Oct 16, 2024 @ 11:01 AM Invivyd to Present PEMGARDAâ„¢ (pemivibart) Da... Source: Globe Newswire Jul 1, 2024 @ 11:01 AM Invivyd Announces its Addition to the Russell 2000... Source: Invivyd Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.2 $-.14 $-.15 Diluted EPS $-1.2 $-.14 $-.15 Revenue $ 36.69M $ 11.3M $ 13.82M Gross Profit $ $ $ Net Income / Loss $ -142.72M $ -16.29M $ -18.44M Operating Income / Loss $ -147.71M $ -16.92M $ -19.23M Cost of Revenue $ $ $ Net Cash Flow $ -141.31M $ -21.26M $ -37.53M PE Ratio